Page 201 - Read Online

Watanabe. J Cancer Metastasis Treat 2018;4:48 I http://dx.doi.org/10.20517/2394-4722.2018.60 Page 3 of 4

thors for their hard work in producing the articles. I also thank Professor Hideo Baba, Department of Gas-
troenterological Surgery, Kumamoto University, for his guidance and support for this project. I am very
happy if you enjoyed this special issue.

DECLARATIONS
Authors’ contributions
The author contributed solely to the article.

Availability of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflicts of interest
The author declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2018.

REFERENCES
1. Sawayama H, Ishimoto T, Baba H. Microenvironment in the pathogenesis of gastric cancer metastasis. J Cancer Metastasis Treat 2018;4:10.
2. Uchihara T, Ishimoto T, Yonemura A, Baba H. Therapeutic targets against gastric cancer stem cells interacting with tumor environment. J
Cancer Metastasis Treat 2018;4:9.
3. Nakamura K, Iwatsuki M, Kurashige J, Ishimoto T, Baba Y, Miyamoto Y, Yoshida N, Watanabe M, Baba H. Circulating tumor cells in
gastric cancer. J Cancer Metastasis Treat 2018;4:32.
4. Komatsu S, Kiuchi J, Imamura T, Ichikawa D, Otsuji E. Circulating microRNAs as a liquid biopsy: a next-generation clinical biomarker for
diagnosis of gastric cancer. J Cancer Metastasis Treat 2018;4:36.
5. Kamiya S, Rouvelas I, Lindblad M, Nilsson M. Current trends in gastric cancer treatment in Europe. J Cancer Metastasis Treat 2018;4:35.
6. Harada K, Baba H, Ajani JA. Recent trend in gastric cancer treatment in the USA. J Cancer Metastasis Treat 2018;4:18.
7. Eto K, Ida S, Watanabe M, Baba H. Treatment strategy for metastatic gastric cancer in Japan. J Cancer Metastasis Treat 2018;4:23.
8. Toihata T, Imamura Y, Watanabe M, Baba H. Management of metastatic esophagogastric junction adenocarcinoma. J Cancer Metastasis
Treat 2018;4:24.
9. Hu QJ, Ito S, Yanagihara K, Mimori K. Molecular mechanism of peritoneal dissemination in gastric cancer. J Cancer Metastasis Treat
2018;4:39.
10. Matsuoka T, Yashiro M. Significance of peritoneal lavage cytology based on genetic signatures in gastric cancer. J Cancer Metastasis Treat
2018;4:6.
11. Sugarbaker PH. Gastric cancer: prevention and treatment of peritoneal metastases. J Cancer Metastasis Treat 2018;4:7.
12. Macedo F, Ladeira K, Longatto-Filho A, Martins SF. Gastric cancer treated with pressurized intraperitoneal aerosol chemotherapy: revising
an option for peritoneal carcinomatosis. J Cancer Metastasis Treat 2018;4:8.
13. Pergolini I, Ciano P, Guercioni G, Catarci M. Surgical treatment of stage IV gastric cancer: is it worthwhile? J Cancer Metastasis Treat
2018;4:33.
14. Ida S, Watanabe M. Conversion surgery for stage IV gastric cancer. J Cancer Metastasis Treat 2018;4:22.
15. Makuuchi R, Irino T, Tanizawa Y, Bando E, Kawamura T, Terashima M. Pancreaticoduodenectomy for gastric cancer. J Cancer Metastasis
Treat 2018;4:26.
16. Kiyozumi Y, Iwatsuki M, Yamashita K, Koga Y, Yoshida N, Baba H. Update on targeted therapy and immune therapy for gastric cancer,
2018. J Cancer Metastasis Treat 2018;4:31.